Chemokines and chemokine receptors in infectious diseases

Immunology and Cell Biology

Volumn 77, Issue 6, 1999, Pages 469-475

  Mahalingam, Surendran ^a,b   Karupiah, Gunasegaran ^b  

^a UNIVERSITY OF CANBERRA   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Chemokine receptors; Chemokines; Cytokines; Human immunodeficiency virus infection

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA CHEMOKINE; INTERFERON; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFECTION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; REVIEW; VIRUS INFECTION;

ANIMALS; ANTIGENS, PROTOZOAN; CARRIER PROTEINS; CHEMOKINES; COMMUNICABLE DISEASES; CYTOMEGALOVIRUS INFECTIONS; HAPLORHINI; HIV INFECTIONS; HUMANS; MICE; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; VIRAL PROTEINS;

BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MAMMALIA;

EID: 0032738096     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00858.x     Document Type: Review

References (77)

1. 1 Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes: More than an attraction. Immunity 1998; 9: 1-11.
2. 2 Oppenheim JJ, Zachariae C, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu. Rev. Immunol. 1991; 9: 617-48.
3. 3 Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 1994; 12: 593-633.
4. 4 Kelner GS, Kennedy J, Bacon KB et al. Lymphotactin: A cytokine that represents a new class of chemokine. Science 1994; 266: 1395-9.
5. 5 Pan Y, Lloyd C, Zhou H et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997; 387: 611-17.
6. 6 Bazan JF, Bacon KB, Hardiman G et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640-4.
7. 7 Kennedy J, Kelner GS, Kleyensteuber S et al. Molecular cloning and functional characterization of human lymphotactin. J. Immunol. 1995; 155: 203-9.
8. 8 Clark-Lewis I, Kim KS, Rajarathnam K et al. Structure-activity relationships of chemokines. J. Leukoc. Biol. 1995; 57: 703-11.
9. 9 Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 1994; 55: 97-179.
10. 10 Loetscher M, Gerber B, Loetscher P et al. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 1996; 184: 963-9.
11. 11 Cole KE, Strick CA, Paradis TJ et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 1998; 187: 2009-21.
12. 12 Qin S, Rottman JB, Myers P et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 1998; 101: 746-54.
13. 13 D'Apuzzo M, Rolink A, Loetscher M et al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 1997; 27: 1788-93.
14. 14 Bleul CC, Wu L, Hoxic JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl Acad. Sci. USA 1997; 94: 1925-30.
15. 15 Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine I, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 1998; 187: 655-60.
16. 16 Gao JL, Kuhns DB, Tiffany HL et al. Structure and functional expression of the human macrophage inflammatory protein I alpha/RANTES receptor. J. Exp. Med. 1993; 177: 1421-7.
17. 17 Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a CC chemokinc receptor. Cell 1993; 72: 415-25.
18. 18 Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR. Molecular cloning and functional expression of two monocyte chemoattractant protein I receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl Acad. Sci. USA 1994; 91: 2752-6.
19. 19 Ben-Baruch A, Xu L, Young PR, Bengali K, Oppenheim JJ, Wang JM. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKRI, a receptor for macrophage inflammatory protein-1 alpha/RANTES, is also a functional receptor for MCP3. J. Biol. Chem. 1995; 270: 22 123-8.
20. 20 Combadiere C, Ahuja SK, Van Damme J, Tiffany HL, Gao JL, Murphy PM. Monocytc chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J. Biol. Chem. 1995; 270: 29 671-5.
21. 21 Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, Wang JM. Monocyte chemotactic protein-2 (MCP-2) uses CCRI and CCR2B as its functional receptors. J. Biol. Chem. 1997; 272: 11 682-5.
22. 22 Uguccioni M, Loetscher P, Forssmann U et al. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 1996; 183: 2379-84.
23. 23 Combadiere C, Ahuja SK, Murphy PM. Cloning and functional expression of a human cosinophil CC chemokine receptor. J. Biol. Chem. 1995; 270: 16 491-4.
24. 24 Ponath PD, Qin S, Post TW et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on cosinophils. J. Exp. Med. 1996; 183: 2437-48.
25. 25 Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005-7.
26. 26 Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 1997; 272: 15 036-42.
27. 27 Imai T, Chantry D, Raport CJ et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 1998; 273: 1764-8.
28. 28 Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1 (alpha), MIP-1 (beta), and RANTES. J. Leukoc. Biol. 1996; 60: 147-52.
29. 29 Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 505-8.
30. 30 Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1 beta, and MIP-1 alpha. J. Biol. Chem. 1996; 271: 17 161-6.
31. 31 Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J. Immunol. 1999; 162: 186-94.
32. 32 Yoshida R, Imai T, Hieshima K et al. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J. Biol. Chem. 1997; 272: 13 803-9.
33. 33 Tiffany HL, Lautens LL, Gao JL et al. Identification of CCR8: A human monocyte and thymus receptor for the CC chemokine 1-309. J. Exp. Med. 1997; 186: 165-70.
34. 34 Zaballos A, Gutierrez J, Varona R, Ardavin C, Marquez G. Cutting edge: Identification of the orphan chemokine receptor GPR-9 6 as CCR9, the receptor for the chemokine TECK, J. Immunol. 1999; 162: 5071-5.
35. 35 Bonini JA, Martin SK, Dralyuk F, Roe MW, Philipson LH, Steiner DF. Cloning, expression, and chromosomal mapping of a novel human CC chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell. Biol. 1997; 16: 1249-56.
36. 36 Yoshida T, Imai T, Kakizaki M, Nishimura M, Takagi S, Yoshie O. Identification of single C motif-1/lymphotactin receptor XCRI. J. Biol. Chem. 1998; 273: 16 551-4.
37. 37 Imai T, Hieshima K, Haskell C et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-30.
38. 38 Smith GL, Symons JA, Khanna A, Vanderplasschen A, Alcami A. Vaccinia virus immune evasion. Immunol. Rev. 1997; 159: 137-54.
39. 39 Cao JX, Gershon PD, Black DN. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. Virology 1995; 209: 207-12.
40. 40 Massung RF, Jayarama V, Moyer RW, DNA sequence analysis of conserved and unique regions of swinepox virus: Identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology 1993; 197: 511-28.
41. 41 Krathwohl MD, Hromas R, Brown DR, Broxmeyer HE, Fife KH. Functional characterization of the CC chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2. Proc. Natl Acad. Sci. USA 1997; 94: 9875-80.
42. 42 Lalani AS, McFadden G. Secreted poxvirus chemokine binding proteins. J. Leukoc. Biol. 1997; 62: 570-6.
43. 43 Mossman K, Nation P, Macen J, Garbutt M, Lucas A, McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 1996; 215: 17-30.
44. 44 Graham KA, Latani AS, Macen JL et al. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 1997; 229: 12-24.
45. 45 Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 1998; 160: 624-33.
46. 46 Martinez-Pomares L, Thompson JP, Moyer RW. Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. Virology 1995; 206: 591-600.
47. 47 Ahuja SK, Gao JL, Murphy PM. Chemokine receptors and molecular mimicry. Immunol. Today 1994; 15: 281-7.
48. 48 Gao JL, Murphy PM. Human cytomegalovirus open reading frame US28 encodes a functional β chemokine receptor. J. Biol. Chem. 1994; 269; 28 539-42.
49. 49 Kuhn DE, Beall CJ, Kolattukudy PE. The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem. Biophys. Res. Commun. 1995; 211: 325-30.
50. 50 Rawlinson WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 1996; 70: 8833-49.
51. 51 Albrecht JC, Nicholas J, Biller D et al. Primary structure of the herpesvirus saimiri genome. J. Virol. 1992; 66: 5047-58.
52. 52 Ahuja SK, Murphy PM. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J. Biol. Chem. 1993; 268: 20 691-4.
53. 53 Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. Erythrocyte receptors for (Plasmodium knowlesi) malaria; Duffy blood group determinants. Science 1975; 189: 561-3.
54. 54 Craigen JL, Yong KL, Jordan NJ et al. Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 1997; 92: 138-45.
55. 55 Murayama T, Kuno K, Jisaki F et al. Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J. Virol. 1994; 68: 7582-5.
56. 56 Khabar KS, Al-Zoghaibi F, Al-Ahdal MN et al. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J. Exp. Med. 1997; 186: 1077-85.
57. 57 Harrowe G, Cheng-Mayer C. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 1995; 210: 490-4.
58. 58 Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P. The V3 domain of the HIV-1 gp120 envelope glyco-protein is critical for chemokine-mediated blockade of infection. Nat. Med. 1996; 2: 1244-7.
59. 59 Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1α, and MIP-β as the major HIV-suppressive factors produced by CD8 T cells. Science 1995; 270: 1811-15.
60. 60 Paxton WA, Martin SR, Tse D et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 1996; 2: 412-17.
61. 61 Feng Y, Broder CC, Kennedy PC, Berger EA. HIV-1 entry co-factor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872-7.
62. 62 Bleul CC, Farran M, Choe H et al. The lymphocyte chemoattractant SDF-I is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829-33.
63. 03 Oberlin E, Amara A, Bachelerie F et al. The CXC chemokine SDF-I is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382: 833-5.
64. 64 Alkhatib G, Combadiere C, Broder CC et al. CC CKR5: A RANTES, MIP-lalpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272; 1955-8.
65. 65 Deng H, Liu R, Ellmeier W et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661-6.
66. 66 Dragic T, Litwin V, Allaway GP et al. HIV-1 entry into CD4-cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-73.
67. 67 Choe H, Farzan M, Sun Y et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85: 1135-48.
68. 68 Doranz BJ, Rucker J, Yi Y et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996; 85: 1149-58.
69. 69 Dean M, Carrington M, Winkler C et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273: 1856-62.
70. 70 Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the xCCR-5 chemokine receptor gene. Nature 1996; 382: 722-5.
71. 71 O'Brien TR, Winkler C, Dean M et al. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 1997; 349: 1219.
72. 72 Paxton WA, Kang S. Chemokine receptor allelic polymorphisms: Relationships to HIV resistance and disease progression. Semin. Immunol. 1998; 10: 187-94.
73. 73 Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 1997; 185: 621-8.
74. 74 Liao F, Alkhatib G, Peden KW, Sharma G, Berger EA, Farber JM. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 1997; 185: 2015-23.
75. 75 Pal R, Garzino-Demo A, Markham PD, Burns J et al. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 1997; 278: 695-8.
76. 76 Horuk R, Hesselgesser J, Zhou Y et al. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J. Biol. Chem. 1998; 273: 386-91.
77. 77 Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997; 276: 1874-8.